This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Image Credits: Stämm Biotech. Image Credits: Stämm Biotech. The movement itself acts as the stirring motion.
“Using this legacy hardware to cultivate meat requires one to reengineer the cells. Our approach and core conviction is that it is actually easier, and ultimately better, to design new hardware systems aimed to foster the growth around the cells, rather than trying to fit these cells to existing engineering systems.”
Lambda , $480M, artificial intelligence: Lambda, which offers cloud computing services and hardware for training artificial intelligence software, raised a $480 million Series D co-led by Andra Capital and SGW. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025.
Those 50 companies that raised large rounds in October ranged across many sectors, including AI, data centers, nuclear energy, biotech, semiconductors, fintech, space and robotics. The second-largest sector, healthcare and biotech, raised around $5.6 Still, AI led But AI was still by far the leading sector, with $12.2
3 tips for biotech startups seeking non-dilutive capital to weather the downturn. Most biotech founders who are looking to raise in this environment assume that dilutive capital is their only option, but that’s short-sighted, writes James Coates, Health and Human Performance principal at Decisive Point.
By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device.
The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Going from service to hardware sales and support is the current roadmap. Berkeley has a big new biotech incubator in Bakar Labs.
The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. I asked Almogy what he felt were the areas of the biotech and medical industry that will benefit most from this new capability.
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.
Pae Wu and Garrett Winther are both partners at SOSV and run the fund’s programs around biotech and hardware. At TechCrunch Early Stage: Marketing and Fundraising, two experienced investors spoke on the subject and advised startups facing a challenging fundraising path.
These rising-star startups represent the innovation taking place across these tech categories: Hardware, Robotics, AI + ML. HealthTech + BioTech. Winnowing the group to 200 companies was a challenging, exhausting thrill ride, and we could not be more excited by the results. Space + Security. SaaS, Enterprise + Retail.
The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. “We’ve had to build an entirely new hardware stack that allows for this kind of automation,” ElSayed said.
The Early Stage Pitch-Off is open to companies from around the world, consumer or enterprise and in any industry — biotech, space, mobility, impact, SaaS, hardware, sustainability and more. . Our last pitch-off had one of the most geographically diverse batches from a TC event. Apply today!
billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI. Close to two-thirds of these large Series A companies in H1 2024 are in healthcare/biotech. While total funding reached $31.5 Other sectors got short shrift.
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space. New Zealanders make really good founders.
” Breaking the numbers down by industry, on average: Hardware company CEOs are near the bottom of the pack, with an average salary of $112,000 per year. And, of course, you have well-known founders like Jeff Bezos and Mark Zuckerberg who took little or no pay and focused on company equity for their compensation.”
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” while hardware production happened in China. When asked why the company straddles China and the U.S.,
It is then tech and industry agnostic, which means that these companies can be hardware, software but also deeptech, biotech or fintech startups. With this program, Techstars is looking for companies working on water, energy, waste management and other sustainability-related issues.
The pre-seed round was led by Latin America-focused biotech investor Zentynel Frontier Investments , with participation from academic incubation investors VentureWell , mission-driven impact investor ImpactAssets and a few additional angels from the United States and Latin America. .”
a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. An organ-on-a-chip is pretty much exactly what it sounds like: it’s a recreation of a human organ (or system of human organs) scaled down into a tiny piece of hardware about the size of a AA battery. Emulate Inc.,
Healthcare and AI lead The leading sector for investment was healthcare and biotech companies which raised $6 billion. The next largest sectors for funding in July were hardware companies, raising $3.3 Biotech and healthcare companies have dominated billion-dollar exits this year. billion, and financial services at $2.6
Another big week for biotech, as startups in the sector scooped up multiple spots on this week’s list. Seaport Therapeutics , $225M, biotech: Seaport Therapeutics isn’t new to this list. The biotech company focuses on medicines for depression, anxiety and other neuropsychiatric disorders. billion post-money valuation.
The Dallas-based startup, which launched in 2021, plans to use the money to continue to advance its genetic engineering technologies, as well as grow its software and hardware solutions for applications involved with de-extinction, conservation and human health care.
Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. The company offers cloud computing services and hardware for training artificial intelligence software. Freenome , $254M, biotech: This is just the first of many big biotech raises this week. billion valuation.
Automated driving company Wayve , data preparation company Scale AI and AI biotech company Xaira Therapeutics each raised billion-dollar rounds. Healthcare and biotech was the second-largest sector, raising $17 billion. Hardware companies — in large part due to AI infrastructure and semiconductor fundings — raised $11 billion.
There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech and sometimes even a space startup. But amid the regular flow of funding news, it’s still rare to come across a company raising money to take on addiction with software.
Once again, biotech made up nearly a third of the list while some other sectors that don’t usually make the list — developer platform and analytics — were represented. Uniquity Bio , $300M, biotech: It has become pretty much the norm to start off these lists with a big biotech raise. billion valuation.
NextMind debuted its Dev Kit hardware at CES last year, but the hardware is now actually shipping out , and the startup shared with me the production version to take a test drive. Bottom line. NextMind’s Dev Kit is definitely just that – a Dev Kit.
in H1 2024 was concentrated in larger bets, and in two leading industries, healthcare/biotech and AI, according to an analysis of Crunchbase data. AI-related companies represented 40% of companies and healthcare/biotech around 25%. Healthcare and AI lead The increase in funding at Series A and B in the U.S.
“Their investment in Mimi is another testament not only to the depth and breadth of the German venture capital climate, but also to the importance and tremendous commercial potential of Mimi’s vision.” ”
Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications Capgemini Nov 6, 2024 Facebook Linkedin The BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. This year, there was a different vibe compared to last year. Nevertheless, it is crucial to start now.
Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. “Lateral flow,” in this case, is the same type of testing you’ve seen from at-home pregnancy or COVID-19 tests.
Mavenir builds cloud-native software that allows enterprises and service providers to manage complex networks without relying on older telecom hardware such as routers and switches. CinRx Pharma , $73M, biotech: This week’s top biotech round isn’t as big as it is on most weeks, but that follows the general trend.
AI surpassed healthcare and biotech, the second-largest sector, which raised more than $15 billion. Hardware, the third-largest sector, raised more than $13 billion. By far, large early-stage rounds were dominated by AI and biotech. Financial services companies, meanwhile, raised close to $8 billion.
However, they seem to think it’s weaker in design, hardware, fintech, robotics and agritech. The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. Weak: Hardware-based startups (better in Delft/Eindhoven). Utrecht is a bit lagging.”
But much of the industry is still in its infancy, partly because of a lack of domain experts and software tools that match the progress of quantum hardware. Quantum computers have the potential to carry out highly complicated calculations in minutes that would have taken classical computers thousands of years to work out.
The fourth company is a biotech firm interested in synthetic biology. One is a company focusing on cancer care and neurological disorders, which has been using Volta’s tech to develop a DNA extraction process. One is a research institution in RNA applications. The third is a “genome center,” he says.
That usually entails deploying all sorts of petri-dish-based microbiological monitoring, hardware and waiting for tests to return from labs. The factories which process our food and beverages (newsflash: no, it doesn’t come straight from a farm) have to be kept very clean, or we’d all get very ill, to be blunt. All rights reserved.
In addition to the standard array of wearable sensors, the startup points to a custom-built EDA (electrodermal activity) detector as the product’s hardware differentiator. The company is offering a hardware-as-a-service model, straight out of the gate. There’s no upfront cost for the hardware, with plans starting at $20 a month.
It has announced the upcoming launch of connected hardware that’s designed to monitor the “health” of your home, as its marketing puts it. Indian wearable startup Ultrahuman is getting into the smart home game.
TechCrunch’s Hardware Battlefield editor Neesha Tambe is conducting the interview. Chrissy Meyer knows hardware. I’m excited to have Gurjeet speaking at an upcoming TechCrunch Live event on March 29 at 12 pm PDT. Oma Fertility investor Chrissy Meyer is speaking at the event, too.
Top sectors Biotech and healthcare was the leading sector by funding amount in April. Other leading sectors in April include hardware startups, which collectively raised $3.3 Companies in that space raised $5.7 billion, or around 26% of all funding, according to Crunchbase data. AI companies raised $3.9 billion; manufacturing ($2.9
Ensuring that usually entails deploying petri-dish-based microbiological monitoring, hardware and waiting for tests to return from labs. The factories that process our food and beverages (newsflash: no, it doesn’t come straight from a farm) have to be kept very clean, or we’d all get very ill, to be blunt. All rights reserved.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content